suMMARY Fifty four men with anogenital warts were studied; 22 had concurrent infection with the human immunodeficiency virus (HIV). The median duration ofthe warts before and after the start of treatment of seven HIV infected and 10 non-infected heterosexual men was similar. In homosexual men, however, the duration of the lesions in 15 HIV infected patients was greater before and after treatment than in 22 non-HIV infected men. As the median number of CD4+ cells in the peripheral blood was significantly lower in homosexual than heterosexual men infected with HIV, the difference in the course of anogenital warts in homosexual compared with heterosexual men may reflect different degrees of immunosuppression.
Anogenital warts caused by human papillomavirus (HPV) are common in patients who attend genitourinary medicine clinics and, in the absence of specific antiviral chemotherapy, can be difficult to eradicate. After variable periods, however, they usually regress, even ifthey have not been treated. ' The immunological mechanisms that result in resolution of wart virus infection are largely unknown, but cell mediated immune responses are probably important.2 Anogenital warts occur in about 40% of homosexual men infected with the human immunodeficiency virus (HIV),3 and, as HIV can produce-pronounced impairment ofcellular immunity, condylomata acuminata in men with HIV infection might be expected to have a somewhat protracted course. Surprisingly, few data on this aspect of HPV infection have been published. The aim ofthe present study was to learn something of the natural history of anogenital warts in men infected with HIV.
Patients and methods

PATIENTS
The study group comprised 54 men with anogenital warts who attended the department of genitourinary medicine of this hospital as "new" or "return new" patients in June to December 1984 We used the Wilcoxon rank test to analyse the data.
Results
The table summarises the findings in the study groups. In each case, the warts were of the hyperplastic type.' CLINICAL COURSE OF ANOGENITAL WARTS Heterosexual men Of 17 heterosexual men available for assessment three years after the initial clinic attendance, seven had antibody to HIV, each having acquired his infection by sharing contaminated syringes and needles. Thirteen heterosexual men had perianal condylomata, but warts were not found within the anal canal. The differences between HIV infected and non-infected men in the median duration of the warts before treatment (9 v 3 months), the duration after the start of treatment (24 v 9 months), or the number oftreatments required (10 v 5) were not significant.
Homosexual men
The median duration of anogenital warts before treatment was significantly higher (p < 0.01) in HIV infected men than in non-infected men. Similarly, the median duration of warts after the start of treatment (36 v 9.5 months) and the median number of treatments given (20 v 4) were significantly greater in men infected with HIV (in each case p < 0.0 1). Sixteen men (seven with and nine without antibodies to HIV) had condylomata of the anal canal, which were not treated other than by obtaining tissue by punch biopsy for histological examination (data not shown start of treatment, or numbers of treatments given to HIV infected compared with non-infected men. The total number of patients, however, was small, and a larger series of patients would be required to confirm or refute these findings. The homosexual men in our study showed a significant difference in the course of the warts between HIV infected and non-infected men. Although intraanal warts are known to have a more protracted course, even in the absence of immunodeficiency,6 in our patients, the duration of perianal and anal warts was greater in men with antibody to HIV. This finding differed from that of von Krogh et al, who found that 32 1% of men with and 40-4% of men without antibody to HIV had anal warts for more than 12 months, a difference that was not significant. 6 The duration of follow up of their patients was not stated, however, and more prolonged surveillance may have shown a significant difference between the two groups. Another factor that may explain the differences between our findings and those of von Krogh and the differences in durations of warts between our homosexual and heterosexual patients could be the degree of impairment of cell mediated immunity.
As the duration ofHIV infection increases, there is a progressive reduction in the number of CD4+ cells in the peripheral blood and progressive impairment of cellular immunity.5 In our patients, the median number of CD4+ cells in the blood of HIV infected homosexual men was significantly lower than in heterosexuals. That may reflect differences in the duration of HIV infection or in exposure to antigenic stimuli such as spermatozoa. Thus the differences between our homosexual and heterosexual HIV infected patients in the course of anogenital warts may result from differences in degrees of impairment of cellular immunity.
Although intraepithelial carcinoma has been recorded in HIV infected men with anal warts,7 we did not find this in any of the biopsied lesions. Human papillomavirus types 16 or 18, which are associated with genital tract malignancy,8 were detected by in situ hybridisation in warts from three of our patients, two of whom had antibody to HIV. Rudlinger et al. however, did not identify these types in perianal or anal warts from HIV infected men or women in Ziurich.9 As HPV types 16 and 18 tend to be associated with non-condylomatous lesions,'`and as colposcopy of the anal canal was not undertaken, the prevalence may be higher than recorded in those two studies.
In conclusion, our data suggest that anogenital warts in HIV infected homosexual men run a protracted course, but anal malignancy appears to be uncommon. As HPV types associated with carcinomas of the anogenital regions can be identified in genital and anal condylomata, the perianal region and anal canal should be examined regularly to detect early neoplastic changes. 
